Pradeep Chaluvally-Raghavan, PhD

Publications

• Protocol for the isolation of tumor cell-derived extracellular vesicles followed by in vivo metastasis assessment in a murine ovarian cancer model.

  (Mittal S, Kumar S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S.) STAR Protoc. 2024 Jun 21;5(2):102943 PMID: 38470912 PMCID: PMC10945248 SCOPUS ID: 2-s2.0-85187377383 03/12/2024

• Blocking Oncostatin M receptor abrogates STAT3 mediated integrin signaling and overcomes chemoresistance in ovarian cancer.

  (Geethadevi A, Ku Z, Tsaih SW, Parashar D, Kadamberi IP, Xiong W, Deng H, George J, Kumar S, Mittal S, Zhang N, Pradeep S, An Z, Chaluvally-Raghavan P.) NPJ Precis Oncol. 2024 Jun 05;8(1):127 PMID: 38839865 PMCID: PMC11153533 SCOPUS ID: 2-s2.0-85195471255 06/06/2024

• Protocol for the isolation of tumor cell-derived extracellular vesicles followed by in vivo metastasis assessment in a murine ovarian cancer model

  (Mittal S, Kumar S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S.) STAR Protocols. 21 June 2024;5(2) SCOPUS ID: 2-s2.0-85187377383 06/21/2024

• Preclinical activity of selinexor in combination with eribulin in uterine leiomyosarcoma.

  (Mittal S, Kadamberi IP, Chang H, Wang F, Kumar S, Tsaih SW, Walker CJ, Chaluvally-Raghavan P, Charlson J, Landesman Y, Pradeep S.) Exp Hematol Oncol. 2023 Sep 15;12(1):78 PMID: 37715291 PMCID: PMC10503035 SCOPUS ID: 2-s2.0-85171339411 09/16/2023

• Fluorinated triphenylphosphonium analogs improve cell selectivity and in vivo detection of mito-metformin.

  (AbuEid M, Keyes RF, McAllister D, Peterson F, Kadamberi IP, Sprague DJ, Chaluvally-Raghavan P, Smith BC, Dwinell MB.) iScience. 2022 Dec 22;25(12):105670 PMID: 36567718 PMCID: PMC9768319 12/27/2022

• Metabolic Reprogramming in Tumor-Associated Macrophages in the Ovarian Tumor Microenvironment.

  (Kumar S, Mittal S, Gupta P, Singh M, Chaluvally-Raghavan P, Pradeep S.) Cancers (Basel). 2022 Oct 25;14(21) PMID: 36358644 PMCID: PMC9656653 SCOPUS ID: 2-s2.0-85141848301 11/12/2022

• Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies.

  (McAlarnen LA, Gupta P, Singh R, Pradeep S, Chaluvally-Raghavan P.) Mol Ther Oncolytics. 2022 Sep 15;26:347-359 PMID: 36090475 PMCID: PMC9420349 09/13/2022

• Optimized proximity ligation assay (PLA) for detection of RNA-protein complex interactions in cell lines.

  (George J, Mittal S, Kadamberi IP, Pradeep S, Chaluvally-Raghavan P.) STAR Protoc. 2022 Jun 17;3(2):101340 PMID: 35620072 PMCID: PMC9127197 SCOPUS ID: 2-s2.0-85130357879 05/28/2022

• Correction: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance. Cancers 2022, 14, 958.

  (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P.) Cancers (Basel). 2022 May 16;14(10) PMID: 35626175 PMCID: PMC9140135 05/29/2022

• Fluorinated triphenylphosphonium analogs improve cell selectivity and in vivo detection of mito-metformin

  (AbuEid M, Keyes RF, McAllister D, Peterson F, Kadamberi IP, Sprague DJ, Chaluvally-Raghavan P, Smith BC, Dwinell MB.) Iscience. 22 December 2022;25(12) SCOPUS ID: 2-s2.0-85143723525 12/22/2022

• Extracellular vesicle contents as non-invasive biomarkers in ovarian malignancies

  (McAlarnen LA, Gupta P, Singh R, Pradeep S, Chaluvally-Raghavan P.) Molecular Therapy Oncolytics. 15 September 2022;26:347-359 SCOPUS ID: 2-s2.0-85136664501 09/15/2022

• Correction to: Parashar et al. Patient-Derived Ovarian Cancer Spheroids Rely on PI3K-AKT Signaling Addiction for Cancer Stemness and Chemoresistance (Cancers, (2022), 14, 958)

  (Parashar D, Geethadevi A, Mittal S, McAlarnen LA, George J, Kadamberi IP, Gupta P, Uyar DS, Hopp EE, Drendel H, Bishop EA, Bradley WH, Bone KM, Rader JS, Pradeep S, Chaluvally-Raghavan P.) Cancers. May-2 2022;14(10) SCOPUS ID: 2-s2.0-85129951244 05/01/2022